2022 Annual Meeting | C17 - COVID-19 in Pediatric Neurology
Program Materials Program Evaluations
| 12:15 PM - 12:45 PM PDT | Speaker |
Introduction and Discussion of Neuroinflammatory Findings in Children with COVID
Grace Gombolay, MD, FAAN |
| 12:15 PM - 02:15 PM PDT | Speaker |
walk in slides
Grace Gombolay, MD, FAAN |
| 12:45 PM - 01:15 PM PDT | Speaker |
Neurological Manifestations of COVID-19 in Critically Ill Pediatric Patients
Mark Wainwright, MD, PhD, FAAN |
| 01:15 PM - 01:45 PM PDT | Speaker |
Neuroimaging Features in Pediatric COVID-19 Patients
Neil Lall, MD |
| 01:45 PM - 02:15 PM PDT | Speaker |
Long-term Neurocognitive and Behavioral Outcomes of MIS-C
Maitreyi Mazumdar, MD |
| Maitreyi Mazumdar, MD | An immediate family member of Dr. Mazumdar has received personal compensation for serving as an employee of Pfizer. An immediate family member of Dr. Mazumdar has received stock or an ownership interest from Pfizer. |
| Neil Lall, MD | Dr. Lall has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for American College of Radiology. |
| Mark Wainwright, MD, PhD, FAAN | Dr. Wainwright has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sage Therapeutics. |
| Grace Gombolay, MD, FAAN | The institution of Dr. Gombolay has received research support from CDC. The institution of Dr. Gombolay has received research support from NIH. Dr. Gombolay has a non-compensated relationship as a Board of Trustee with National MS Society -Georgia chapter that is relevant to AAN interests or activities. |